|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> PCI 34051>> Market Analysis Reports |
Market Analysis Reports of PCI 34051 |
|
Pharmacyclics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... allergic indications; and HDAC8 inhibitors (PCI-34051 and others) that are ... hematological (blood related) cancers. PCI-27483: PCI-27483 is a highly optimized and ... lymphoma in dogs. It initiated a trial of PCI-32765 in spontaneous canine lymphoma in companion ... Histone deacetylase (HDAC) Inhibitors - Competitive Landscape, Market and Pipeline Analysis, 2017 This report can be delivered to the clients within 25 Hours DelveInsight’s, “Histone deacetylase (HDAC) Inhibitors - Competitive Landscape, Market, and Pipeline Analysis, 2017” report provides comprehensive insights of the ongoing therapeutic research and ... |